Vanguard Group Inc Crispr Therapeutics Ag Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Vanguard Group Inc holds 1,769,709 shares of CRSP stock, worth $65.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,769,709
Previous 1,735,998 1.94%
Holding current value
$65.9 Million
Previous $68.3 Million 11.86%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$34.03 - $53.02 $1.15 Million - $1.79 Million
33,711 Added 1.94%
1,769,709 $60.2 Million
Q4 2024

Feb 11, 2025
BUY
$38.65 - $55.15 $408,878 - $583,431
10,579 Added 0.61%
1,735,998 $68.3 Million
Q3 2024

Nov 13, 2024
SELL
$44.62 - $62.75 $1.03 Million - $1.45 Million
-23,094 Reduced 1.32%
1,725,419 $81.1 Million
Q2 2024

Aug 13, 2024
BUY
$51.17 - $68.18 $5.72 Million - $7.62 Million
111,714 Added 6.83%
1,748,513 $94.4 Million
Q1 2024

May 10, 2024
BUY
$60.67 - $89.12 $2.8 Million - $4.11 Million
46,148 Added 2.9%
1,636,799 $112 Million
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $2.01 Million - $3.75 Million
51,926 Added 3.37%
1,590,651 $99.6 Million
Q3 2023

Nov 14, 2023
BUY
$45.39 - $59.0 $346,552 - $450,465
7,635 Added 0.5%
1,538,725 $69.8 Million
Q2 2023

Aug 14, 2023
BUY
$43.47 - $67.77 $2.02 Million - $3.15 Million
46,521 Added 3.13%
1,531,090 $86 Million
Q1 2023

May 15, 2023
BUY
$41.0 - $56.12 $1.73 Million - $2.37 Million
42,292 Added 2.93%
1,484,569 $67.1 Million
Q4 2022

Feb 10, 2023
BUY
$39.19 - $65.67 $269,117 - $450,955
6,867 Added 0.48%
1,442,277 $58.6 Million
Q3 2022

Nov 14, 2022
BUY
$61.1 - $83.78 $6.86 Million - $9.41 Million
112,269 Added 8.49%
1,435,410 $93.8 Million
Q2 2022

Aug 12, 2022
BUY
$43.23 - $73.83 $4.58 Million - $7.82 Million
105,852 Added 8.7%
1,323,141 $80.4 Million
Q1 2022

May 13, 2022
BUY
$53.19 - $79.24 $46.8 Million - $69.8 Million
880,463 Added 261.4%
1,217,289 $76.4 Million
Q4 2021

Feb 14, 2022
SELL
$70.09 - $111.29 $1.66 Million - $2.64 Million
-23,715 Reduced 6.58%
336,826 $25.5 Million
Q3 2021

Nov 12, 2021
BUY
$110.2 - $156.64 $10.7 Million - $15.2 Million
96,783 Added 36.69%
360,541 $40.4 Million
Q2 2021

Aug 13, 2021
BUY
$100.84 - $161.89 $26.6 Million - $42.7 Million
263,758 New
263,758 $42.7 Million

Others Institutions Holding CRSP

# of Institutions
479
Shares Held
64.2M
Call Options Held
2.15M
Put Options Held
1.92M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $2.9B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email